H Michael Shepard

USPTO Granted Patents = 58 (Patent Applications = 20)

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 2.7

ph-index = 17

Forward Citations = 2,094(Granted Patents)

Forward Citations (Not Self Cited) = 1,976(Dec 10, 2025)

Location History:

Santa Fe, CA (US) (1998)
Carlsbad, CA (US) (1998)
San Francisco, CA (US) (1989 - 2003)
Rancho Santa Fe, CA (US) (1997 - 2008)
Encinitas, CA (US) (2004 - 2009)
Rancho Sante Fe, CA (US) (2009)
San Diego, CA (US) (2014 - 2020)
Springfield, OR (US) (2021 - 2023)
Eugene, OR (US) (2024)

Company Filing History:

Celmed Oncology (usa), Inc.

University of California

Northwestern University

patents

9. 1 out of 576

The Salk Institute for Biological Studies

11. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...

Areas of Expertise:

PH20 Polypeptide Variants

Adenosine Deaminase-2

Combination Therapy

Hyaluronan-Degrading Enzyme

Companion Diagnostic

Enzyme Catalyzed Therapeutics

Tumor Necrosis Factor

Monoclonal Antibodies

Gene Therapy

Retinoblastoma Protein

Autoimmune Conditions

Therapy-Resistant Tumors

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371685 - PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof (2025-07-29),

2. 12264345 - PH20 polypeptide variants, formulations and uses thereof (2025-04-01),

3. 12195773 - PH20 polypeptide variants, formulations and uses thereof (2025-01-14),

4. 12152262 - PH20 polypeptide variants, formulations and uses thereof (2024-11-26),

5. 12123035 - PH20 polypeptide variants, formulations and uses thereof (2024-10-22),

6. 12110520 - PH20 polypeptide variants, formulations and uses thereof (2024-10-08),

7. 12104185 - PH20 polypeptide variants, formulations and uses thereof (2024-10-01),

8. 12104184 - PH20 polypeptide variants, formulations and uses thereof (2024-10-01),

9. 12091692 - PH20 polypeptide variants, formulations and uses thereof (2024-09-17),

10. 12077791 - PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof (2024-09-03),

11. 12060590 - PH20 polypeptide variants, formulations and uses thereof (2024-08-13),

12. 12054758 - PH20 polypeptide variants, formulations and uses thereof (2024-08-06),

13. 12049652 - PH20 polypeptide variants, formulations and uses thereof (2024-07-30),

14. 12037618 - PH20 polypeptide variants, formulations and uses thereof (2024-07-16),

15. 12018298 - PH20 polypeptide variants, formulations and uses thereof (2024-06-25),

Title: The Innovative Journey of H Michael Shepard

Introduction: H Michael Shepard is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to the field of biotechnology.

Latest Patents: H Michael Shepard holds several patents in the biotechnology sector, focusing on novel therapies and treatment methods for various medical conditions.

Career Highlights: With a distinguished career spanning several decades, H Michael Shepard has worked tirelessly to develop innovative solutions that have the potential to revolutionize the healthcare industry.

Collaborations: Throughout his career, H Michael Shepard has collaborated with leading researchers, scientists, and institutions to further his research and bring his inventions to life.

Conclusion: H Michael Shepard's dedication to innovation and his passion for creating impactful solutions make him a true pioneer in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.